Related Experiment Video
Updated: May 23, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
[A multicenter study of coronary artery disease and its risk factors in rheumatoid arthritis in China]
Chun Li1, Xiu-ru Wang, Yi-da Tang
1Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing 100044, China.
Insights
The prevalence of coronary artery disease (CAD) in rheumatoid arthritis (RA) patients in China is 3.5%. Advanced age, diabetes, and hypertension are key risk factors, while hydroxychloroquine (HCQ) use shows a protective effect.
Area of Science:
- Rheumatology and Immunology
- Cardiovascular Medicine
- Epidemiology
Context:
- Rheumatoid arthritis (RA) is associated with an increased risk of cardiovascular disease.
- Understanding the specific prevalence and risk factors of coronary artery disease (CAD) in RA patients in China is crucial for targeted prevention strategies.
Purpose:
- To determine the prevalence of coronary artery disease (CAD) among rheumatoid arthritis (RA) patients in China.
- To identify the clinical and social risk factors associated with CAD in this patient population.
Summary:
- A retrospective study of 960 RA patients in China revealed a 3.5% prevalence of CAD, higher than in the general population.
- Independent predictors for CAD in RA patients included older age, diabetes mellitus, and hypertension. Hydroxychloroquine (HCQ) use was found to be a protective factor.
- Factors such as rheumatoid nodules, lung interstitial disease, and specific comorbidities were also noted in the CAD group.
Impact:
- This study highlights the significant burden of CAD in RA patients in China and identifies key modifiable and non-modifiable risk factors.
- Findings emphasize the importance of cardiovascular risk assessment and management in RA patients, particularly those with identified risk factors.
- The protective role of hydroxychloroquine (HCQ) suggests potential therapeutic implications for cardiovascular risk reduction in RA.
Objective:
To learn about the prevalence and risk factors of coronary artery disease (CAD) in rheumatoid arthritis (RA).
Methods:
Data were obtained from a 12-month retrospective investigation of the patients with RA, randomly selected from Departments of Rheumatology and Immunology in 21 big hospitals in China. The data were collected about their social conditions, clinical conditions, medications associated with RA, such as disease modifying anti-rheumatic drugs (DMARDs), non steroidal anti-inflammatory drugs (NSAIDs), glucocorticoid, biologic agents. A nonparameter test and multivariate logistic regression analysis were performed.
Results:
In the study, 960 patients were enrolled. The prevalence of CAD was 3.5% in China, which was obviously higher than that of normal people. The prevalence of overweight and obesity, smoking, hypertension, diabetes mellitus, hypercholesterolemia and cerebrovascular disease were 35.1%, 12.3%, 17.0%, 7.7%, 0.4% and 3.0%, respectively. Compared with the control group, the CAD group had higher age [(64.7±9.3) years vs. (52.3±14.0) years,P<0.001], more rheumatoid nodules (14.7% vs. 3.1%,P=0.005), lower rate of hydroxychloroquine (HCQ) use (5.9% vs. 22.6%,P=0.021), higher prevalence rates of lung interstitial disease (17.5% vs. 7.0%,P<0.001), diabetes mellitus and hypertension (29.4% vs. 7.0%,P<0.001; 38.2% vs. 16.2%,P=0.001). There was no obvious correlation of CAD in RA with joint deformity, rheumatoid factor (RF) titer, glucocorticoid use, hypercholesterolemia and body mass index (BMI). Multivariate analysis showed higher age, diabetes mellitus and hypertension were independent predictors of CAD, and the use of HCQ was a protective factor of CAD.
Conclusion:
The prevalence of CAD is 3.5%. Higher age, diabetes mellitus and hypertension are independent predictors of CAD, and the use of HCQ is a protective factor of CAD.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease I: Introduction
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Rheumatic Heart Disease III: Medical Management
Coronary Artery Disease I: Introduction
Coronary Artery Disease IV: Preventive Measures